Health Canal, April 22, 2020

UTMB researchers have identified novel mechanisms that contribute to protections against Marburg infection. There are currently no vaccines are drugs approved for human use to protect against the Marburg virus. “Antibodies are currently the most promising platform for developing post-exposure treatments for Marburg virus infection and are critical tools for design of improved vaccines,” said UTMB’s Alex Bukreyev who led the research team. Cell Host & Microbe published the research findings.